Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,512
-$2,369 QoQ
Shares Held
9
-35.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,567
of 2,602 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nemes Rush Group LLC holds $458,035 across 12 Diagnostics & Research names. TMO ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
598 | $316,694 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
525 | $101,440 | |
| 3 | NTRA |
Natera, Inc.
|
51 | $13,843 | |
| 4 | DHR |
Danaher Corp /De/
|
29 | $5,523 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
This page
|
9 | $4,512 | |
| 6 | ILMN |
Illumina, Inc.
|
23 | $4,044 | |
| 7 | WAT |
Waters Corp /De/
|
9 | $3,375 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2 | $2,555 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,512 | 9 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,881 | 14 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,056 | 7 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $2,838 | 7 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,985 | 6 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,121 | 6 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||